Oral Administration of Unstable or Poorly-Absorbed Drugs
AssigneeInnopharmax, Inc.
InventorsYu-Tsai YANG, Jong-Jing WANG, Pei-Jing HSU, Li-Chien CHANG, Wei-Hua HAO, Chang-Shan HSU
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnopharmax, Inc.
InventorsYu-Tsai YANG, Jong-Jing WANG, Pei-Jing HSU, Li-Chien CHANG, Wei-Hua HAO, Chang-Shan HSU
Estimating the term…
The disclosure relates to a dosage forms and combinations of dosage forms useful for effective oral administration of drugs which are otherwise unsuitable for oral administration, owing to acid- and/or protease-mediated degradation. The dosage forms include a self-microemulsifying drug delivery system (SMEDDS) with which the drug is combined and an antacid. When co-administered to a mammal, the dosage form(s) can prevent drug degradation by the strong acid and digestive enzymes normally present in the gastric environment, and can improve water-soluble drug absorption in gastrointestinal (GI) tract. The dosage forms can be used to effectively administer insulin by an oral route, for example, such as in the form of a powder that can be stored for long periods and reconstituted with water or another fluid shortly before administration.
A dosage form for orally administering a gastrically impractical drug to the bloodstream of a mammal, the dosage form comprising
A kit comprising
A method of orally administering a gastrically impractical drug to the bloodstream of a mammal, the method comprising:
A method of orally administering a gastrically impractical drug to the bloodstream of a mammal, the method comprising:
Dependencies are inferred from the claim text.